REGULUS THERAPEUTICS INC - COM NEW (RGLS) Institutional Ownership

CUSIP: 75915K200

13F Institutional Holders and Ownership History from Q1 2016 to Q3 2024

Type / Class
Equity / COM NEW
Symbol
RGLS on Nasdaq
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 75915K200?
CUSIP 75915K200 identifies RGLS - REGULUS THERAPEUTICS INC - COM NEW in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Institutional Holders of REGULUS THERAPEUTICS INC - COM NEW (RGLS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q3 0 $0 -$11,577,366 0
2024 Q2 6,467,802 $11,577,366 $1.79 1
2024 Q1 6,467,802 $18,627,270 +$13,024,002 $2.88 1
2023 Q4 1,945,579 $2,490,341 $1.28 1
2023 Q3 1,945,579 $2,665,443 $1.37 1
2023 Q2 1,945,579 $2,860,001 +$735,684 $1.47 1
2023 Q1 1,445,114 $1,224,734 $0.85 1
2022 Q4 1,445,114 $1,979,806 -$1 $1.37 1
2022 Q3 1,445,115 $2,457,000 $1.70 1
2022 Q2 1,445,115 $2,991,000 -$40,686,994 $2.07 1
2022 Q1 60,661,369 $18,074,000 +$9,813,926 $0.30 36
2021 Q4 30,169,407 $9,535,000 -$1,032,200 $0.32 36
2021 Q3 22,960,336 $15,856,000 -$142,911 $0.69 38
2021 Q2 23,064,442 $18,736,000 -$7,718,708 $0.81 43
2021 Q1 27,287,166 $42,568,129 +$14,984,655 $1.56 42
2020 Q4 18,410,400 $24,803,224 +$14,493,226 $1.35 28
2020 Q3 7,808,182 $4,013,085 +$668,963 $0.51 22
2020 Q2 6,330,314 $4,312,113 -$1,059,157 $0.68 29
2020 Q1 8,615,363 $3,970,077 +$671,672 $0.46 22
2019 Q4 7,152,864 $6,367,148 -$308,402 $0.89 19
2019 Q3 7,707,004 $5,549,120 -$1,723,591 $0.72 22
2019 Q2 9,062,294 $11,330,208 +$8,032,017 $1.25 21
2019 Q1 2,654,240 $2,706,169 +$42,170 $1.02 22
2018 Q4 2,624,560 $2,439,420 +$2,322,910 $0.92 21
2018 Q3 127,085 $25,000 +$25,000 $0.20 1
2016 Q2 0 $0 -$1,000 0
2016 Q1 833 $1,000 $1.20 1